Was that Bernie Maddoff

First 88 Last

Share
Profile

Follow
Dovif

1,957 Posts.

69

20/03/18

21:12

Post #: 31899535
Share

Originally posted by clown333 ↑

Don't forget the Weinstein of analysts

Aesir Initiates with a Price Target of A$7.33 which Represents a 50/50 blend of our Comparables (EV/Sales) and Discounted Cash Flow Methodologies for ~200% UpsideWith the current pipeline ramp-up and the NA Williams deal fully deployed, GetSwift should be on track to do ~A$200m revenue comfortably in CY2020. GetSwift’s peer universe is richly valued for markedly less growth than GetSwift offers, albeit the companies are significantly more mature in their life cycle. Given GSW’s superior growth profile and margin structure, it is fair to assume that it could trade at ~10x EV/Sales based on 2019 sales projections which would equate to $2.06 billion enterprise value ($1.982 billion market cap), resulting in a $9.31/share fair value for the common equity in 2018. To sense-check that number, we used a discount cash flow model with Aesir NOPAT projections to 2022, a terminal growth of 5% and tax rate of 30%. To reflect the high level of execution risk, we opted for a 20% discount rate which results in an NPV/share of $5.34. As a thought exercise, Aesir elected to reverse engineer the share price to see what the implied discount rate the market was assigning to the Company’s projected cash flows. Under our assumptions, a 40% discount rate equates to a A$2.40 share price. This suggests that the market is still in ‘wait and see’ mode with regards to whether the management can fully execute on their current contracted deals and more interestingly, the market is attaching zero value to GSW’s deal pipeline, including the one other ‘embargo deal’ that management references in its presentation materials. This represents a substantial opportunity

Expand

Was that Bernie Maddoff

GSW Price at posting: 52.0¢ Sentiment: Hold Disclosure: Not Held
5 Upvote

0 Great analysis

Reply

Top Stories

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BUX

Buxton projects new graphite province discovery at WA Narryer play

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

There are more pages in this discussion • 111 more messages in this thread...

First 88 Last

Add GSW (ASX) to my watchlist

Was that Bernie Maddoff

Top Stories

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Buxton projects new graphite province discovery at WA Narryer play

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News